These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2184326)

  • 21. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
    Hecker LI; Saavedra JE; Farrelly JG; Andrews AW
    Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenicity in V79 cells does not correlate with carcinogenity in small rodents for 12 aromatic amines.
    Fassina G; Abbondandolo A; Mariani L; Taningher M; Parodi S
    J Toxicol Environ Health; 1990; 29(1):109-30. PubMed ID: 2299684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the UKEMS in the development of testing guidelines.
    Kirkland DJ
    Mutagenesis; 2002 Nov; 17(6):451-5. PubMed ID: 12435841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals.
    Mortelmans K; Haworth S; Lawlor T; Speck W; Tainer B; Zeiger E
    Environ Mutagen; 1986; 8 Suppl 7():1-119. PubMed ID: 3516675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interlaboratory Pig-a gene mutation assay trial: Studies of 1,3-propane sultone with immunomagnetic enrichment of mutant erythrocytes.
    Dertinger SD; Phonethepswath S; Weller P; Avlasevich S; Torous DK; Mereness JA; Bryce SM; Bemis JC; Bell S; Portugal S; Aylott M; MacGregor JT
    Environ Mol Mutagen; 2011 Dec; 52(9):748-55. PubMed ID: 22052433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new statistical method for evaluation of L5178Ytk(+/-) mammalian cell mutation data using microwell method.
    Omori T; Honma M; Hayashi M; Honda Y; Yoshimura I
    Mutat Res; 2002 May; 517(1-2):199-208. PubMed ID: 12034321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statistical analysis of data in mutagenicity assays: rodent micronucleus assay.
    Hayashi M; Hashimoto S; Sakamoto Y; Hamada C; Sofuni T; Yoshimura I
    Environ Health Perspect; 1994 Jan; 102 Suppl 1(Suppl 1):49-52. PubMed ID: 8187724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing between expert and statistical systems for application under ICH M7.
    Barber C; Hanser T; Judson P; Williams R
    Regul Toxicol Pharmacol; 2017 Mar; 84():124-130. PubMed ID: 28057482
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of control groups in mutagenicity studies: matching biological and statistical relevance.
    Hauschke D; Hothorn T; Schäfer J
    Altern Lab Anim; 2003 Jun; 31 Suppl 1():65-75. PubMed ID: 15595901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parametric analysis of rank transformed data for statistical assessment of genotoxicity data with examples from cultured mammalian cells.
    Mitchell IG; Amphlett NW; Rees RW
    Mutagenesis; 1994 Mar; 9(2):125-32. PubMed ID: 8201945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rodent mutation assay data presentation and statistical assessment.
    Ashby J
    Mutat Res; 1995 Oct; 331(2):233-5. PubMed ID: 7500983
    [No Abstract]   [Full Text] [Related]  

  • 33. The UKEMS collaborative genotoxicity trial organisation, selection criteria and preparation of the chemicals.
    Ashby J; Parry JM; Arlett CF; Coombs MM
    Mutat Res; 1982; 100(1-4):1-6. PubMed ID: 7057744
    [No Abstract]   [Full Text] [Related]  

  • 34. A nonparametric approach to the statistical analysis of mutagenicity data.
    Wahrendorf J; Mahon GA; Schumacher M
    Mutat Res; 1985; 147(1-2):5-13. PubMed ID: 3974612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critique of the collaborative cytogenetics study to measure and minimize interlaboratory variation.
    Weil CS
    Mutat Res; 1978 May; 50(2):285-91. PubMed ID: 349375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A statistical analysis of the third UKEMS collaborative trial.
    Green MH; Cook SK; Cole J; Arlett CF
    Mutagenesis; 1990; 5 Suppl():71-84. PubMed ID: 2184326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microwell mutation assays: evaluation of ethylmethanesulphonate, benzo[a]pyrene and benzidine using the tk locus in L5178Y mouse lymphoma cells.
    Clay P; Cross MF
    Mutagenesis; 1990; 5 Suppl():45-54. PubMed ID: 2184320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chinese hamster ovary (CHO/HPRT) cell mutation assays with EMS, benzo[a]pyrene and benzidine.
    Phillips BJ; Tee AC; Carroll PA; Anderson D
    Mutagenesis; 1990; 5 Suppl():15-20. PubMed ID: 2184315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the activities of benzo[a]pyrene, benzidine and ethyl methanesulphonate in the L5178Y TK +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols.
    Riach CG; Cattanach PJ; Howgate S; Shepherd W; McBride D; Edwards IW; McGregor DB; Combes RD
    Mutagenesis; 1990; 5 Suppl():35-44. PubMed ID: 2184319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The third United Kingdom Environmental Mutagen Society collaborative trial: overview, a summary and assessment.
    Arlett CF; Cole J
    Mutagenesis; 1990; 5 Suppl():85-8. PubMed ID: 2184327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.